CN106770832A - Ginseng and pilose antler strengthening the essence tablet quality control method - Google Patents

Ginseng and pilose antler strengthening the essence tablet quality control method Download PDF

Info

Publication number
CN106770832A
CN106770832A CN201710007091.5A CN201710007091A CN106770832A CN 106770832 A CN106770832 A CN 106770832A CN 201710007091 A CN201710007091 A CN 201710007091A CN 106770832 A CN106770832 A CN 106770832A
Authority
CN
China
Prior art keywords
solution
ginseng
ginsenoside
butanol
methyl alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710007091.5A
Other languages
Chinese (zh)
Other versions
CN106770832B (en
Inventor
吕宏迪
王海伟
王自勤
段国方
张正臣
李文俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
No159 Hospital Of Pla
Original Assignee
No159 Hospital Of Pla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by No159 Hospital Of Pla filed Critical No159 Hospital Of Pla
Priority to CN201710007091.5A priority Critical patent/CN106770832B/en
Publication of CN106770832A publication Critical patent/CN106770832A/en
Application granted granted Critical
Publication of CN106770832B publication Critical patent/CN106770832B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/74Optical detectors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90Plate chromatography, e.g. thin layer or paper chromatography

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of ginseng and pilose antler strengthening the essence tablet quality control method, using the Radix Astragali and ginseng in thin-layered chromatography discriminating medicine;Using main active ginsenoside Rg in high effective liquid chromatography for measuring medicine1(C42H72O14) and ginsenoside Re (C48H82O18) content.Ginseng and pilose antler strengthening the essence tablet quality control method of the invention, with stronger specificity and good reappearance, can better control over drug quality, really meet effective, the quality controllable requirement of drug safety.

Description

Ginseng and pilose antler strengthening the essence tablet quality control method
Technical field
The invention belongs to technical field of pharmaceuticals, specifically, it is related to a kind of ginseng and pilose antler strengthening the essence tablet quality control method.
Background technology
In recent years, China's Cancer Mortality, the death rate are in sustainable growth trend.According to national tumor center's epidemiology Research report:20 years from now on, the morbidity and mortality of China's malignant tumour will also persistently rise.If do not adopted an effective measure, The year two thousand twenty, China's pathogenesis of cancer number and death toll will rise to 4,000,000 people and 3,000,000 people;The year two thousand thirty will rise to 5,000,000 people and 3500000 people.Surgical operation, radiation and chemotherapy is the common method of current clinical treatment malignant tumour.But radiation and chemotherapy is being controlled Often cause serious side effect while treatment, cause the symptoms such as Neuroleptic Leukocytopenia, hemoglobin reduction.According to another report, China's hepatitis, The hepatitis B incidence of disease shows lasting ascendant trend, accounts for the 20% of outpatient service viral hepatitis patient's total amount, causes cirrhosis, liver cancer Major incentive.Hepatitis C early stage non-evident sympton, is easily ignored by patient, and there is no effective hcv vaccine at present, many Number patient goes to a doctor in cirrhosis compensatory phase, Decompensated stage, has missed best occasion for the treatment, and prognosis is poor.Hepatitis B be widely current in Countries in the world, seriously threaten human health, main to invade children and person between twenty and fifty, and small number of patients can be converted into cirrhosis or liver cancer. Hepatitis B can fall ill throughout the year without specific epizootic modeling, be that current China is popular the most extensively, harmfulness most serious diseases it One.Interferon and Ribavirin are usually used in the clinical treatment of hepatitis and hepatitis B, but often cause patient leucocyte, hemoglobin occur The side effects such as reduction.
Ginseng and pilose antler strengthening the essence piece prescription in the case where the famous expert Miao Mingsan of China is instructed;The party by American Ginseng, the Radix Astragali, the fruit of glossy privet, when Return, the red sage root, the bighead atractylodes rhizome, Chinese yam, the fruit of Chinese magnoliavine, garden burnet, hawthorn, cynomorium songaricum, pilose antler, the tuber of dwarf lilyturf, the 14 taste Chinese medicines such as the fruit of Chinese wolfberry are constituted.Its work( Can be veins takes off admittedly, tonifying spleen benefit liver, blood-nourishing of promoting the production of body fluid, tranquilize the mind and promote the intelligence invigorating kidney yang, benefiting essence-blood, strengthening the bones and muscles.Suffer from suitable for hepatitis, hepatitis B The Neuroleptic Leukocytopenia occurred after person's conventional therapy or tumor patient chemicotherapy, hemoglobin is low and altitude sickness and indigestion Etc. symptom.14 medicines are shared, collect veins takes off admittedly, tonifying spleen benefit liver, blood-nourishing of promoting the production of body fluid, tranquilize the mind and promote the intelligence invigorating kidney yang, benefiting essence-blood, strengthening the bones and muscles it Work(is both paid attention to dredging vascular in one, to improve internal organs blood supply, human body allomeric function and metabolism can be improved again, reaches righting and dispels The purpose of heresy.The prescription is first used for some patientss by prescriptions of traditional Chinese medicine, obtains satisfactory effect.After producing and processing into preparation, in clinic Upper small range is tried out, determined curative effect.
According to the ginseng and pilose antler strengthening the essence tablet quality standard formulated, it is ensured that the stability and curative effect of preparation.Ginseng and the Radix Astragali are ginseng and pilose antler Main flavour of a drug in strengthening the essence piece, this law is using ginsenoside Rg in high-efficient liquid phase technique other side1Assay is carried out with Re, with thin layer color Spectrum is respectively to ginseng and Radix Astragali Qualitive test.The long-term stable experiment result of preparation shows, in 24 months, the quality of preparation without Significant change, for the term of validity for formulating preparation provides strong evidence.
The content of the invention
In view of this, the technical problems to be solved by the invention are to provide a kind of method of quality control of ginseng and pilose antler strengthening the essence piece, The method can fast and accurately differentiate the Radix Astragali and ginseng in ginseng and pilose antler strengthening the essence piece, and be joined by high effective liquid chromatography for measuring Ginsenoside Rg in fine and soft strengthening the essence piece1With the content of ginsenoside Re.
The invention discloses a kind of ginseng and pilose antler strengthening the essence tablet quality control method, Radix Astragali discriminating is carried out using thin-layered chromatography Differentiate with ginseng;Ginsenoside Rg is carried out using high performance liquid chromatography1With ginsenoside Re's assay.
Further, the Radix Astragali discrimination method is:Ginseng and pilose antler strengthening the essence piece 3g is taken, is removed and is coated, it is finely ground into powder;To described Powder adds methyl alcohol 20ml, is heated to reflux 1h, filters, and filtrate is evaporated, and residue adds water 30ml dissolvings, then uses n-butanol water saturation Solution is extracted 2 times, each 20ml, merges n-butanol extracting liquid, washes the n-butanol extracting liquid with water 2 times, and each 20ml is abandoned Aqueous are gone, the n-butanol liquid after washing is evaporated, residue adds methyl alcohol 0.5ml to dissolve, used as need testing solution;
Astragaloside IV is taken, plus methyl alcohol is made reference substance solutions of every 1ml containing 1mg;
Methyl alcohol is taken as negative control solution;
According to thin-layered chromatography experiment, above-mentioned each 2 μ l of three kinds of solution are drawn, put respectively on same silica gel g thin-layer plate, with body Product is than being 13:7:2 chloroform-methanol-water is solvent in 10 DEG C of lower floor's solution arranged below, is launched, and is taken out, and is dried in the air It is dry, spray with 10% ethanol solution of sulfuric acid, it is heated to spot development at 105 DEG C clear;
Observation silica gel g thin-layer plate, inspects under fluorescent lamp, in test sample chromatogram, on position corresponding with reference substance chromatogram, The sepia spot of aobvious same color.
Further, the ginseng discrimination method is:Ginseng and pilose antler strengthening the essence piece 5g is taken, is removed and is coated, it is finely ground into powder;Will be described Powder is put in conical flask with cover, adds methyl alcohol 50ml, is heated to reflux 2h, lets cool, and filters, and measures subsequent filtrate 25ml and is evaporated, residue The 30ml that adds water dissolves, and is extracted 2 times with chloroform, and each 30ml discards chloroform liquid, then shaken with n-butanol water saturation solution Extraction 5 times is shaken, each 20ml merges n-butanol extracting liquid, washed with ammonia solution 2 times, each 30ml, then use n-butanol water saturation Solution 30ml is washed, and is taken n-butanol liquid and is evaporated, and residue adds methyl alcohol 1ml to dissolve, used as need testing solution;
Take ginsenoside Rg_1 and Re plus methyl alcohol be made every 1ml respectively mixed reference substance solutions containing 2mg,
Methyl alcohol is taken as negative control solution;
According to thin-layered chromatography experiment, the μ l of need testing solution 10 are drawn, the μ l of the reference substance solution 5, negative control is molten The μ l of liquid 5, put on same silica gel g thin-layer plate, are 4 with volume ratio:1:5 n-butanol-ethyl acetate-water is arranged below at 10 DEG C Upper solution be solvent, launch, take out, dry, spray with 10% ethanol solution of sulfuric acid, be heated to spot development at 105 DEG C Clearly;
Observation silica gel g thin-layer plate, puts and inspect under fluorescent lamp, in test sample chromatogram, in position corresponding with reference substance chromatogram On, show the spot of same color.
Further, the ginsenoside Rg1It is with ginsenoside Re's content assaying method:
Chromatographic condition and system suitability:With octadecylsilane chemically bonded silica as filler;It is flowing with acetonitrile Phase A, with water as Mobile phase B, carries out gradient elution;Column temperature is 40 DEG C;Flow velocity 1.0ml/min, Detection wavelength is 203nm, theoretical The number of plates calculates >=6000 by ginsenoside Rg1 peak;
The gradient is:
Time (min) Mobile phase A % Mobile phase B %
0-45 18 82
45-70 18→28 82→72
70-100 28→40 72→60
The preparation of reference substance solution:Precision weighs 0.2mg ginsenoside Rgs respectively1Reference substance, ginsenoside Re's reference substance, Plus 1ml methyl alcohol, shake up and be made mixed solution, obtain final product;
The preparation of need testing solution:Take ginseng and pilose antler strengthening the essence piece 10g, remove and be coated, it is finely ground into powder, in putting conical flask with cover, Add methyl alcohol 50ml, be heated to reflux 2h, let cool, filter, measure subsequent filtrate 25ml and be evaporated, residue add water 30ml dissolving, use positive fourth The shaking of alcohol water saturation solution is extracted 5 times, and each 20ml merges n-butanol extracting liquid, is washed with ammonia solution 2 times, each 30ml, then Washed with n-butanol water saturation solution 30ml, take n-butanol liquid and be evaporated, residue adds methyl alcohol to dissolve and be transferred in 10ml measuring bottles, plus Methanol dilution shakes up to scale, filtration, takes subsequent filtrate, obtains final product;
Assay method:It is accurate respectively to draw reference substance solution and each 10 μ l of need testing solution, inject liquid chromatograph, record Chromatogram, by external standard method with ginsenoside Rg in calculated by peak area test sample1With the total amount of ginsenoside Re, this product every is containing people Ginseng is with ginsenoside Rg1(C42H72O14) and ginsenoside Re (C48H82O18) total amount meter be no less than 0.20mg.
Compared with prior art, the present invention can be obtained including following technique effect:
1) ginseng and pilose antler strengthening the essence tablet quality control method of the invention, there is provided the method for differentiating ginseng and the Radix Astragali in medicine, and Main flavour of a drug ginseng is with ginsenoside Rg in using high-efficient liquid phase technique other side1(C42H72O14) and ginsenoside Re (C48H82O18) be Index carries out assay.
2) method of quality control of the invention can better control over the quality of medicine, with stronger specificity and good Reappearance, real embodiment drug safety is effective, quality controllable.
Certainly, implementing any product of the invention must be not necessarily required to while reaching all the above technique effect.
Brief description of the drawings
Accompanying drawing described herein is used for providing a further understanding of the present invention, constitutes a part of the invention, this hair Bright schematic description and description does not constitute inappropriate limitation of the present invention for explaining the present invention.In the accompanying drawings:
The Radix Astragali differentiates thin-layer chromatogram (fluorescent lamp) during Fig. 1 show the embodiment of the present invention 1;
Ginseng differentiates thin-layer chromatogram (fluorescent lamp) during Fig. 2 show the embodiment of the present invention 2;
Fig. 3 show ginsenoside Rg in the embodiment of the present invention 31With ginsenoside Re's assay reference substance efficient liquid phase Chromatogram;
Fig. 4 show ginsenoside Rg in the embodiment of the present invention 31With ginsenoside Re's assay test sample efficient liquid phase Chromatogram;
Fig. 5 show ginsenoside Rg in the embodiment of the present invention 31With ginsenoside Re's efficient liquid of assay negative control Phase chromatogram.
Specific embodiment
Describe embodiments of the present invention in detail below in conjunction with drawings and Examples, thereby how the present invention is applied Technological means can fully understand and implement according to this to solve technical problem and reach the implementation process of technology effect.
Embodiment 1, the discriminating of the Radix Astragali
Ginseng and pilose antler strengthening the essence piece 3g is taken, is conventionally removed and is coated, it is finely ground into powder, to addition methyl alcohol 20ml in powder, 1h is heated to reflux, is filtered, filtrate is evaporated, residue adds water 30ml dissolvings, then extract 2 times with n-butanol water saturation solution, every time 20ml, merge n-butanol extracting liquid, wash n-butanol extracting liquid with water 2 times, each 20ml discards aqueous, by after washing just Butanol liquid is evaporated, and residue adds methyl alcohol 0.5ml to dissolve, used as need testing solution.
Astragaloside IV is taken, plus methyl alcohol is made reference substance solutions of every 1ml containing 1mg.
Methyl alcohol is taken as negative control solution.
According to thin-layered chromatography experiment, above-mentioned each 2 μ l of three kinds of solution are drawn, put respectively on same silica gel g thin-layer plate, with three (volume ratio is 13 to chloromethanes-methanol-water:7:2) it is solvent in 10 DEG C of lower floor's solution arranged below, launches, take out, dries in the air It is dry, spray with 10% ethanol solution of sulfuric acid, spot development is heated at 105 DEG C clearly, silica gel g thin-layer plate is inspected under fluorescent light.
Inspect result under fluorescent lamp as shown in figure 1, in figure 1 be Astragaloside IV reference substance, 2,3,4 be test sample, 5 for feminine gender Control sample.In figure in test sample chromatogram, on position corresponding with Astragaloside IV reference substance chromatogram, show the spot of same color Point.In negative control sample chromatogram, with Astragaloside IV reference substance chromatogram relevant position on, have no corresponding spot.Show ginseng Contain the Radix Astragali in fine and soft strengthening the essence piece.
Embodiment 2, the discriminating of ginseng
Ginseng and pilose antler strengthening the essence piece 5g is taken, is conventionally removed and is coated, it is finely ground into powder, put in conical flask with cover, add first Alcohol 50ml, is heated to reflux 2h, lets cool, filtration, measures subsequent filtrate 25ml and is evaporated, and residue adds water 30ml dissolvings, is transferred to point liquid and leaks In bucket, shaken with chloroform and extracted 2 times, each 30ml discards chloroform liquid, then carried with the shaking of n-butanol water saturation solution Take 5 times, each 20ml, merge n-butanol extracting liquid, washed with ammonia solution 2 times, each 30ml, then with n-butanol water saturation solution 30ml is washed, and is taken n-butanol liquid and is evaporated, and residue adds methyl alcohol 1ml to dissolve, used as need testing solution.
Take ginsenoside Rg_1 and Re plus methyl alcohol is made every 1ml respectively mixed reference substance solutions containing 2mg.
Methyl alcohol is taken as negative control solution.
According to thin-layered chromatography experiment, the μ l of need testing solution 10 are drawn, the μ l points of reference substance solution 5 are in same silica gel g thin-layer plate On, with n-butanol-ethyl acetate-water, (volume ratio is 4:1:5) it is solvent in 10 DEG C of upper solutions arranged below, launches, Take out, dry, spray with 10% ethanol solution of sulfuric acid, spot development is heated at 105 DEG C clearly, inspect under fluorescent light.Solvent As negative control.
Result as shown in Fig. 2 in figure 1 be ginsenoside Rg1, Re mixing reference substances, 2,3,4 is test sample, and 5 is negative right Product in the same old way.In figure in test sample chromatogram, with ginsenoside Rg1, on the corresponding position of Re mixing reference substance chromatograms, show identical face The spot of color.In negative control sample chromatogram, with ginsenoside Rg1, on Re reference substance chromatograms relevant position, have no corresponding Spot.Show to contain ginseng in ginseng and pilose antler strengthening the essence piece.
Embodiment 3, ginsenoside Rg1With ginsenoside Re's assay
(1) method of assay
Ginseng is main flavour of a drug in ginseng and pilose antler strengthening the essence piece, this law use high-efficient liquid phase technique other side in ginseng with ginsenoside Rg1 With ginsenoside Re for index carries out assay.
Chromatographic condition and system suitability:With octadecylsilane chemically bonded silica as filler;It is flowing with acetonitrile Phase A, with water as Mobile phase B, carries out gradient elution;Column temperature is 40 DEG C;Flow velocity 1.0ml/min, Detection wavelength is 203nm, theoretical The number of plates calculates >=6000 by ginsenoside Rg1 peak.
The gradient is:
The preparation of reference substance solution:Precision weighs 0.2mg ginsenoside Rgs respectively1Reference substance, ginsenoside Re's reference substance, Plus 1ml methyl alcohol, shake up and be made mixed solution, obtain final product.
The preparation of need testing solution:Ginseng and pilose antler strengthening the essence piece 10g is taken, is conventionally removed and is coated, it is finely ground into powder, put tool In plug conical flask, methyl alcohol 50ml is added, be heated to reflux 2h, let cool, filtered, measured subsequent filtrate 25ml and be evaporated, residue adds water 30ml Dissolving, is transferred in separatory funnel, is shaken with n-butanol water saturation solution and extracted 5 times, each 20ml, merges n-butanol and extracts Liquid, is washed 2 times, each 30ml with ammonia solution, then is washed with n-butanol water saturation solution 30ml, is taken n-butanol liquid and is evaporated, residue Plus methyl alcohol dissolves and is transferred in 10ml measuring bottles, plus methanol dilution is to scale, shakes up, filtration, takes subsequent filtrate, obtains final product.
Assay method:Accurate absorption need testing solution and each 10 μ l of reference substance solution are injected separately into liquid chromatograph respectively, Determine, record chromatogram, ginsenoside Rg in test sample is gone out with calculated by peak area by external standard method1With the total amount of ginsenoside Re.
This product every is containing ginseng with ginsenoside Rg1(C42H72O14) and ginsenoside Re (C48H82O18) total amount meter it is many In 0.20mg.
(2) methodological study of assay
The determination of 2.1 Detection wavelengths
Ginsenoside Rg1Without absorption maximum in the range of 200-400nm, there are absorption, the selected detection of bibliography in end Wavelength is 203nm.
2.2 system suitabilities
Under above-mentioned chromatographic condition, reference substance solution, need testing solution and negative control solution (solvent) are taken respectively, respectively enter The μ l of sample 10, record chromatogram, and measurement result is as in Figure 3-5.Ginsenoside Rg in sample1Theoretical cam curve is calculated:N= 16450 (> 6000);Main peak is 1.455 with the separating degree of impurity peaks;Negative control solution is at reference substance absworption peak without absorption; Show that auxiliary material and various catabolites disturb smaller to main peak, meet the requirement of system suitability.
2.3 linear relationships are tested
The accurately weighed ginsenoside Rg of difference1Reference substance and ginsenoside Re's reference substance, are placed in same measuring bottle, prepare adult Ginseng saponin(e Rg1, ginsenoside Re mixed reference substance solution (contain ginsenoside Rg1For 0.53mg/ml, ginsenoside Re are 0.37mg/ml), respectively precision measure 1,2,3,4,5ml, be placed in 10ml measuring bottles, plus dilution in acetonitrile is to scale, shakes up.It is accurate Each 10 μ l of above-mentioned solution are measured, liquid chromatograph is injected separately into according to above-mentioned chromatographic condition, determine peak area.It is right with peak area (Y) Sample introduction concentration (X, mg/ml) carries out linear regression, ginsenoside Rg1Regression equation is Y=840083x-3421.2, coefficient correlation R=0.9999;Ginsenoside Re's regression equation is Y=891838x-1660, and coefficient R=0.9999. results show, ginseng Saponin(e Rg1 concentration in the range of 0.053-0.265mg/ml, ginsenoside Re's concentration in the range of 0.037-0.185mg/ml, peak Area is good with concentration linear relationship, the results are shown in Table 1.
The ginsenoside Rg of table 11With ginsenoside Re's linear relationship result of the test
2.4 minimum detectable activities
No. 1 solution under line taking sexual intercourse experiment item, precision measures 2ml, and in putting 10ml measuring bottles, plus mobile phase is diluted to quarter Degree, shakes up, and precision measures 10 μ l, is injected separately into liquid chromatograph, determines, in chromatogram, signal to noise ratio > 10:1, so minimum inspection Output<0.2μg/ml.
2.5 precision tests
No. 3 solution under line taking sexual intercourse experiment item, precision measures 10 μ l, and METHOD FOR CONTINUOUS DETERMINATION 6 times the results are shown in Table 2, show this Method precision is good.
The Precision test result of table 2
2.6 stability tests
Ginseng and pilose antler strengthening the essence piece is taken, need testing solution is prepared into by assay lower section method;Precision draw need testing solution with Reference substance solution, sample introduction is distinguished in 0h, 1h, 2h, 4h, 8h and 24h, and the μ l of each sample size 10 record peak area value.The results are shown in Table 3, reference substance and sample test liquid are good in 24h internal stabilities.
The stability test result of table 3
Determine number of times Ginsenoside Rg1Peak area Ginsenoside Re's peak area
0 364589 300214
1 359831 303279
2 363962 297205
4 367921 298965
8 366965 303816
24 361918 299018
Average value 364198 300416
RSD% 0.83 0.87
2.7 reappearance tests
Ginseng and pilose antler strengthening the essence piece is taken, 6 parts of need testing solutions is prepared by assay lower section method, respectively by assay lower section Method is determined, and calculates content.4 are the results are shown in Table, sample average content is 0.293mg/ml, RSD=0.89%, investigate method repetition Property is good.
The reproducible test results of table 4
Determine number of times 1 2 3 4 5 6
Total content (mg/ pieces) 0.291 0.294 0.296 0.295 0.293 0.289
2.8 recovery tests
The sample of known content is taken, it is finely ground, 1g is taken, it is accurately weighed, plus ginsenoside Rg1Reference substance solution (0.53mg/ Ml) 1ml and ginsenoside Re's reference substance solution (0.37mg/ml) 1ml, is prepared by need testing solution preparation method, determines peak face Product, calculates measured amount, the results are shown in Table 5, and the sample average rate of recovery is 1.04% for 99.30%, RSD.
The recovery test result of table 5
Ginseng and pilose antler strengthening the essence tablet quality control method of the invention, there is provided differentiate the method for ginseng and the Radix Astragali in medicine, and adopt With main flavour of a drug ginseng in high-efficient liquid phase technique other side with ginsenoside Rg1(C42H72O14) and ginsenoside Re (C48H82O18) it is finger Mark carries out assay.Method of quality control of the invention can better control over the quality of medicine, with stronger specificity and Good reappearance, real embodiment drug safety is effective, quality controllable.
Some vocabulary have such as been used to censure special component or method in the middle of specification and claim.Art technology Personnel are, it is to be appreciated that different regions may call same composition with different nouns.This specification and claims are not In the way of the difference of title is used as distinguishing composition.As the "comprising" of the specification in the whole text and claim mentioned in is One open language, therefore " include but be not limited to " should be construed to." substantially " refer to this area in receivable error range Technical staff can solve the technical problem in the range of certain error, basically reach the technique effect.Specification is follow-up It is described as implementing better embodiment of the invention, so the description is for the purpose of illustrating rule of the invention, not It is used to limit the scope of the present invention.Protection scope of the present invention ought be defined depending on the appended claims person of defining.
Also, it should be noted that term " including ", "comprising" or its any other variant be intended to nonexcludability Comprising, so that commodity or system including a series of key elements not only include those key elements, but also including without clear and definite Other key elements listed, or it is this commodity or the intrinsic key element of system also to include.In the feelings without more limitations Under condition, the key element limited by sentence "including a ...", it is not excluded that in the commodity or system including the key element also There is other identical element.
Described above has shown and described some preferred embodiments of the invention, but as previously described, it should be understood that the present invention Be not limited to form disclosed herein, be not to be taken as the exclusion to other embodiment, and can be used for various other combinations, Modification and environment, and can be in invention contemplated scope described herein, by above-mentioned teaching or the technology or knowledge of association area It is modified.And the change and change that those skilled in the art are carried out do not depart from the spirit and scope of the present invention, then all should be in this hair In the protection domain of bright appended claims.

Claims (4)

1. ginseng and pilose antler strengthening the essence tablet quality control method, it is characterised in that carry out Radix Astragali discriminating and ginseng using thin-layered chromatography Differentiate;Ginsenoside Rg is carried out using high performance liquid chromatography1With ginsenoside Re's assay.
2. ginseng and pilose antler strengthening the essence tablet quality control method as claimed in claim 1, it is characterised in that the Radix Astragali discrimination method is: Ginseng and pilose antler strengthening the essence piece 3g is taken, is removed and is coated, it is finely ground into powder;Methyl alcohol 20ml is added to the powder, 1h is heated to reflux, filtered, filter Liquid is evaporated, and residue adds water 30ml dissolvings, is then extracted 2 times with n-butanol water saturation solution, each 20ml, merges n-butanol and extracts Liquid, washes the n-butanol extracting liquid with water 2 times, and each 20ml discards aqueous, the n-butanol liquid after washing is evaporated, residue Plus methyl alcohol 0.5ml dissolvings, as need testing solution;
Astragaloside IV is taken, plus methyl alcohol is made reference substance solutions of every 1ml containing 1mg;
Methyl alcohol is taken as negative control solution;
According to thin-layered chromatography experiment, above-mentioned each 2 μ l of three kinds of solution are drawn, put respectively on same silica gel g thin-layer plate, with volume ratio It is 13:7:2 chloroform-methanol-water is solvent in 10 DEG C of lower floor's solution arranged below, is launched, and is taken out, and is dried, and is sprayed With 10% ethanol solution of sulfuric acid, spot development is heated at 105 DEG C clear;
Observation silica gel g thin-layer plate, inspects under fluorescent lamp, in test sample chromatogram, on position corresponding with reference substance chromatogram, shows phase With the sepia spot of color.
3. ginseng and pilose antler strengthening the essence tablet quality control method as claimed in claim 1, it is characterised in that the ginseng discrimination method is: Ginseng and pilose antler strengthening the essence piece 5g is taken, is removed and is coated, it is finely ground into powder;During the powder put into conical flask with cover, methyl alcohol 50ml, heating are added Backflow 2h, let cool, filter, measure subsequent filtrate 25ml and be evaporated, residue add water 30ml dissolving, with chloroform extract 2 times, every time 30ml, discards chloroform liquid, then shakes extraction 5 times with n-butanol water saturation solution, and each 20ml merges n-butanol and extracts Liquid, is washed 2 times, each 30ml with ammonia solution, then is washed with n-butanol water saturation solution 30ml, is taken n-butanol liquid and is evaporated, residue Plus methyl alcohol 1ml dissolvings, as need testing solution;
Take ginsenoside Rg_1 and Re plus methyl alcohol is made every 1ml respectively mixed reference substance solutions containing 2mg;
Methyl alcohol is taken as negative control solution;
According to thin-layered chromatography experiment, the μ l of need testing solution 10, the reference substance solution 5 μ l, the μ of negative control solution 5 are drawn L, puts on same silica gel g thin-layer plate, is 4 with volume ratio:1:5 n-butanol-ethyl acetate-water is arranged below upper at 10 DEG C Layer solution is solvent, is launched, and is taken out, and is dried, and is sprayed with 10% ethanol solution of sulfuric acid, is heated to spot development at 105 DEG C clear;
Observation silica gel g thin-layer plate, puts and inspect under fluorescent lamp, in test sample chromatogram, on position corresponding with reference substance chromatogram, shows The spot of same color.
4. ginseng and pilose antler strengthening the essence tablet quality control method as claimed in claim 1, it is characterised in that the ginsenoside Rg1And ginseng Saponin(e Re content assaying methods are:
Chromatographic condition and system suitability:With octadecylsilane chemically bonded silica as filler;With acetonitrile as mobile phase A, With water as Mobile phase B, gradient elution is carried out;Column temperature is 40 DEG C;Flow velocity 1.0ml/min, Detection wavelength is 203nm, theoretical tray Number calculates >=6000 by ginsenoside Rg1 peak;
The gradient is:
Time (min) Mobile phase A % Mobile phase B % 0-45 18 82 45-70 18→28 82→72 70-100 28→40 72→60
The preparation of reference substance solution:Precision weighs 0.2mg ginsenoside Rgs respectively1Reference substance, ginsenoside Re's reference substance, plus 1ml Methyl alcohol, shakes up and is made mixed solution, obtains final product;
The preparation of need testing solution:Ginseng and pilose antler strengthening the essence piece 10g is taken, is removed and is coated, it is finely ground into powder, put in conical flask with cover, add Methyl alcohol 50ml, is heated to reflux 2h, lets cool, filtration, measure subsequent filtrate 25ml and be evaporated, residue add water 30ml dissolving, use n-butanol water Saturated solution shaking is extracted 5 times, and each 20ml merges n-butanol extracting liquid, is washed with ammonia solution 2 times, each 30ml, then with just Butanol water saturation solution 30ml is washed, and is taken n-butanol liquid and is evaporated, and residue adds methyl alcohol to dissolve and be transferred in 10ml measuring bottles, plus methyl alcohol Scale is diluted to, is shaken up, filtered, take subsequent filtrate, obtained final product;
Assay method:It is accurate respectively to draw reference substance solution and each 10 μ l of need testing solution, liquid chromatograph is injected, record chromatogram Figure, by external standard method with ginsenoside Rg in calculated by peak area test sample1With the total amount of ginsenoside Re, this product every containing ginseng with Ginsenoside Rg1Total amount meter with ginsenoside Re is no less than 0.20mg.
CN201710007091.5A 2017-01-05 2017-01-05 Ginseng and pilose antler strengthening the essence tablet quality control method Expired - Fee Related CN106770832B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710007091.5A CN106770832B (en) 2017-01-05 2017-01-05 Ginseng and pilose antler strengthening the essence tablet quality control method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710007091.5A CN106770832B (en) 2017-01-05 2017-01-05 Ginseng and pilose antler strengthening the essence tablet quality control method

Publications (2)

Publication Number Publication Date
CN106770832A true CN106770832A (en) 2017-05-31
CN106770832B CN106770832B (en) 2019-03-29

Family

ID=58949655

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710007091.5A Expired - Fee Related CN106770832B (en) 2017-01-05 2017-01-05 Ginseng and pilose antler strengthening the essence tablet quality control method

Country Status (1)

Country Link
CN (1) CN106770832B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008180539A (en) * 2007-01-23 2008-08-07 Kowa Co Confirmation method of gincenoside in medicine preparation
CN104483315A (en) * 2014-11-14 2015-04-01 颈复康药业集团赤峰丹龙药业有限公司 Traditional Chinese medicine preparation lumbus-strengthening kidney-tonifying pill detection method
EP2906233A1 (en) * 2012-10-12 2015-08-19 Indena S.p.A. Formulations for the treatment and prevention of obesity
CN104991022A (en) * 2015-07-07 2015-10-21 中国人民解放军第一五二中心医院 Kidney health oral liquid quality control method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008180539A (en) * 2007-01-23 2008-08-07 Kowa Co Confirmation method of gincenoside in medicine preparation
EP2906233A1 (en) * 2012-10-12 2015-08-19 Indena S.p.A. Formulations for the treatment and prevention of obesity
CN104483315A (en) * 2014-11-14 2015-04-01 颈复康药业集团赤峰丹龙药业有限公司 Traditional Chinese medicine preparation lumbus-strengthening kidney-tonifying pill detection method
CN104991022A (en) * 2015-07-07 2015-10-21 中国人民解放军第一五二中心医院 Kidney health oral liquid quality control method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
国家药典委员会: "《中华人民共和国药典2010年版一部》", 31 January 2010 *

Also Published As

Publication number Publication date
CN106770832B (en) 2019-03-29

Similar Documents

Publication Publication Date Title
CN101036774B (en) Quality control method of compound cantharidin oral preparations
CN107860832B (en) Method for establishing fingerprint of compound rhubarb clear pancreas soup
CN106324161B (en) Treat the quality determining method of the Chinese medicine composition of diabetic nephropathy
CN103197027A (en) Quality control method of astragalus-leech capsules capable of regulating collaterals
CN107991425A (en) A kind of detection method for the Chinese medicine composition for treating traumatic injury
CN112697948B (en) Quality detection method of lung-clearing and toxin-expelling soup established based on fingerprint model
CN102218122B (en) Detection method for sea dragon and gecko oral liquid
CN103344737A (en) Quality control method of traditional Chinese medicine tablet for treating nasosinusitis
CN106645545A (en) Thin-layer chromatographic identification method for licorice root and application thereof
CN112697951B (en) Quality detection method of lung-clearing and toxin-expelling soup established based on thin-layer identification method
CN105628851B (en) A kind of detection method of Chinese medicine preparation
CN106153812A (en) A kind of detection method of the Chinese medicine preparation treating endometriosis
CN102068598B (en) Quality control method of Yangrong Baicao Wan for treating irregular menses caused by hemophthisis
CN102091297A (en) Quality control method for liver health care medicine
CN106706766B (en) A kind of measuring method of the newly-increased detection ingredient of Chinese medicine Tang blade that treating AIDS
CN108459129A (en) A kind of method of quality control of Tetrandra and Poria Decoction composition
CN101391070B (en) Quality control method of traditional Chinese medicine composition with anti-tumor action
CN106770832B (en) Ginseng and pilose antler strengthening the essence tablet quality control method
CN104458954B (en) A kind of dodder formulation granule finger printing and method for building up thereof
CN112834684B (en) Production method of lung-clearing and toxin-expelling soup established based on thin-layer identification method
CN112526045B (en) Method for simultaneously detecting or identifying effective components in heart-soothing and lipid-lowering tablets
CN107064402B (en) A kind of nourishing qi and blood, tonifying kidney and strengthening yang pharmaceutical preparation detection method
CN110095547A (en) The detection method of paeoniflorin content in a kind of body strengthening paste that lengthens one&#39;s life
CN112666281A (en) Production method of lung-clearing and toxin-expelling soup established based on fingerprint model
CN115166066B (en) Quality evaluation method of Qizhu oral liquid for improving white blood cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190329

Termination date: 20200105

CF01 Termination of patent right due to non-payment of annual fee